サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530997

埋め込み型インスリンポンプの市場世界：産業分析、規模、シェア、成長、動向、予測（2024～2034年）

Implantable Insulin Pumps Market (Device Type: Closed-loop Insulin Pump and Open-loop Insulin Pump; and Disease Indication: Type I Diabetes and Type II Diabetes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日: | 発行: Transparency Market Research | ページ情報: 英文 145 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
埋め込み型インスリンポンプの市場世界：産業分析、規模、シェア、成長、動向、予測（2024～2034年）
出版日: 2024年06月20日
発行: Transparency Market Research
ページ情報: 英文 145 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界の埋め込み型インスリンポンプ市場について、2024～2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018～2034年までの世界の埋め込み型インスリンポンプ市場の収益と予測を提供しています。また、2024～2034年までの世界の埋め込み型インスリンポンプ市場の複合年間成長率（CAGR %）も掲載しています。

当レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、埋め込み型インスリンポンプ市場を推察しました。

市場スナップショット
2023年の市場規模 31億米ドル
2034年の市場規模 78億米ドル
CAGR 8.3%

当レポートでは、世界の埋め込み型インスリンポンプ市場の競合情勢について調査しています。世界の埋め込み型インスリンポンプ市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の埋め込み型インスリンポンプ市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 市場分析と予測、2020～2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要合併・買収
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：デバイスタイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：デバイスタイプ別、2020～2034年
    • 閉ループインスリンポンプ
    • オープンループインスリンポンプ
  • 市場魅力分析：デバイスタイプ別

第7章 世界の市場分析と予測：適応疾患別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：適応疾患別、2020～2034年
    • 1型糖尿病
    • 2型糖尿病
  • 市場魅力分析：適応疾患別

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：エンドユーザー別、2020～2034年
    • 病院
    • クリニック
    • ホームケア設定
    • その他
  • 市場魅力分析：エンドユーザー別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋の市場分析と予測

第13章 ラテンアメリカの市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業- 競争マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Medtronic plc
    • F. Hoffmann-La Roche AG
    • SOOIL Developments Co. Ltd.
    • Diamesco Co., Ltd.
    • Apex Medical Devices
    • Tandem Diabetes Care
    • Johnson & Johnson
    • Insulet Corporation
    • Aetna Inc.
    • Diabeloop SACA
図表

List of Tables

  • Table 01: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 02: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 03: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 07: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 08: North America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 11: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 12: Europe Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 15: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 16: Asia Pacific Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 19: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 20: Latin America Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Device Type, 2020-2034
  • Table 23: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 24: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Implantable Insulin Pumps Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by Device Type, 2023
  • Figure 03: Global Implantable Insulin Pumps Market Value Share, by Device Type, 2023
  • Figure 04: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by Disease Indication, 2023
  • Figure 05: Global Implantable Insulin Pumps Market Value Share, by Disease Indication, 2023
  • Figure 06: Global Implantable Insulin Pumps Market Revenue (US$ Bn), by End-user, 2023
  • Figure 07: Global Implantable Insulin Pumps Market Value Share, by End-user, 2023
  • Figure 08: Global Implantable Insulin Pumps Market Value Share, by Region, 2023
  • Figure 09: Global Implantable Insulin Pumps Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 11: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 13: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 14: Global Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Implantable Insulin Pumps Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Implantable Insulin Pumps Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 22: North America Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 23: North America Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 26: North America Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 31: Europe Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 32: Europe Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 35: Europe Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 40: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 41: Asia Pacific Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 44: Asia Pacific Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Implantable Insulin Pumps Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 49: Latin America Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 50: Latin America Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 53: Latin America Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Implantable Insulin Pumps Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Device Type, 2023 and 2034
  • Figure 58: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 59: Middle East & Africa Implantable Insulin Pumps Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 62: Middle East & Africa Implantable Insulin Pumps Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86235

Implantable Insulin Pumps Market - Scope of Report

TMR's report on the global implantable insulin pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global implantable insulin pumps market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global implantable insulin pumps market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the implantable insulin pumps market.

Market Snapshot
Market Value in 2023US$ 3.1 Bn
Market Value in 2034US$ 7.8 Bn
CAGR8.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global implantable insulin pumps market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global implantable insulin pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global implantable insulin pumps market.

The report delves into the competitive landscape of the global implantable insulin pumps market. Key players operating in the global implantable insulin pumps market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global implantable insulin pumps market profiled in this report.

Key Questions Answered in Global implantable insulin pumps Market Report:

  • What is the sales/revenue generated by implantable insulin pumps across all regions during the forecast period?
  • What are the opportunities in the global implantable insulin pumps market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Implantable Insulin Pumps Market - Research Objectives and Research Approach

The comprehensive report on the global implantable insulin pumps market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global implantable insulin pumps market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global implantable insulin pumps market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Implantable Insulin Pumps Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Implantable Insulin Pumps Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Implantable Insulin Pumps Market Analysis and Forecast, by Device Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Device Type, 2020-2034
    • 6.3.1. Closed-loop Insulin Pump
    • 6.3.2. Open-loop Insulin Pump
  • 6.4. Market Attractiveness Analysis, by Device Type

7. Global Implantable Insulin Pumps Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2020-2034
    • 7.3.1. Type I Diabetes
    • 7.3.2. Type II Diabetes
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Implantable Insulin Pumps Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Homecare Settings
    • 8.3.4. Others (Research Institutes, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Implantable Insulin Pumps Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Implantable Insulin Pumps Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Device Type, 2020-2034
    • 10.3.1. Closed-loop Insulin Pump
    • 10.3.2. Open-loop Insulin Pump
  • 10.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 10.4.1. Type I Diabetes
    • 10.4.2. Type II Diabetes
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals
    • 10.5.2. Clinics
    • 10.5.3. Homecare Settings
    • 10.5.4. Others (Research Institutes, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Device Type
    • 10.7.2. By Disease Indication
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Implantable Insulin Pumps Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Device Type, 2020-2034
    • 11.3.1. Closed-loop Insulin Pump
    • 11.3.2. Open-loop Insulin Pump
  • 11.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 11.4.1. Type I Diabetes
    • 11.4.2. Type II Diabetes
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Homecare Settings
    • 11.5.4. Others (Research Institutes, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Device Type
    • 11.7.2. By Disease Indication
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Implantable Insulin Pumps Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Device Type, 2020-2034
    • 12.3.1. Closed-loop Insulin Pump
    • 12.3.2. Open-loop Insulin Pump
  • 12.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 12.4.1. Type I Diabetes
    • 12.4.2. Type II Diabetes
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Homecare Settings
    • 12.5.4. Others (Research Institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Device Type
    • 12.7.2. By Disease Indication
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Implantable Insulin Pumps Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Device Type, 2020-2034
    • 13.3.1. Closed-loop Insulin Pump
    • 13.3.2. Open-loop Insulin Pump
  • 13.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 13.4.1. Type I Diabetes
    • 13.4.2. Type II Diabetes
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Homecare Settings
    • 13.5.4. Others (Research Institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Device Type
    • 13.7.2. By Disease Indication
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Implantable Insulin Pumps Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Device Type, 2020-2034
    • 14.3.1. Closed-loop Insulin Pump
    • 14.3.2. Open-loop Insulin Pump
  • 14.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 14.4.1. Type I Diabetes
    • 14.4.2. Type II Diabetes
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals
    • 14.5.2. Clinics
    • 14.5.3. Homecare Settings
    • 14.5.4. Others (Research Institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Device Type
    • 14.7.2. By Disease Indication
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Medtronic plc
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. F. Hoffmann-La Roche AG
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. SOOIL Developments Co. Ltd.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Diamesco Co., Ltd.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Apex Medical Devices
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Tandem Diabetes Care
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Johnson & Johnson
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Insulet Corporation
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Aetna Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Diabeloop SACA
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview